Editas Medicine EDIT
$ 2.4
-0.41%
Quarterly report 2024-Q3
added 11-04-2024
Editas Medicine Financial Statements 2011-2024 | EDIT
Annual Financial Statements Editas Medicine
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
845 M | 665 M | 1.29 B | 3.6 B | 1.34 B | 1 B | 1.58 B | 550 M | - | - | - | - | - |
Shares |
76 M | 68.7 M | 67.6 M | 58.6 M | 50 M | 47.1 M | 40.3 M | 32.2 M | - | - | - | - | - |
Historical Prices |
11.1 | 9.69 | 19 | 61.4 | 26.4 | 21.7 | 36.5 | 17.4 | - | - | - | - | - |
Net Income |
-153 M | -220 M | -193 M | -116 M | -134 M | -110 M | -120 M | -97.2 M | -73.3 M | -14 M | - | - | - |
Revenue |
78.1 M | 19.7 M | 25.5 M | 90.7 M | 20.5 M | 31.9 M | 13.7 M | 6.05 M | 1.63 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | 1.63 M | - | - | - | - |
Operating Income |
-169 M | -226 M | -193 M | -135 M | -141 M | -114 M | -120 M | -97.2 M | -35.3 M | -12.7 M | - | - | - |
Interest Expense |
-1.6 M | 1.29 M | 37 K | 16.3 M | -137 K | 328 K | 587 K | -57 K | -37.4 M | -928 K | - | - | - |
EBITDA |
-163 M | -220 M | -188 M | -131 M | -138 M | -110 M | -117 M | -96 M | -34.8 M | -13.5 M | - | - | - |
Operating Expenses |
247 M | 246 M | 219 M | 226 M | 161 M | 146 M | 134 M | 103 M | 36.9 M | - | - | - | - |
General and Administrative Expenses |
69.7 M | 70.7 M | 76.2 M | 67.6 M | 64.6 M | 55 M | 50.5 M | 46.3 M | 18.1 M | 7.65 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Editas Medicine
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
82.5 M | 82.3 M | 81.9 M | 81.8 M | 81.6 M | 71.4 M | 68.9 M | 68.8 M | 68.7 M | 68.6 M | 68.5 M | 68.4 M | 68.2 M | 67.9 M | 66 M | 62.6 M | 62.1 M | 55.3 M | 54.6 M | 54.4 M | 49.8 M | 49.1 M | 48.8 M | 48.8 M | 47.4 M | 47 M | 46 M | 44.5 M | 41.3 M | 40.8 M | 36.5 M | 35.8 M | 35.5 M | 35.3 M | 22.3 M | 3.23 M | 2.93 M | 2.22 M | 1.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-62.1 M | -67.6 M | -62 M | - | -45 M | -40.3 M | -49 M | - | -55.7 M | -53.5 M | -50.5 M | - | -39.1 M | -55.3 M | -56.7 M | -62.5 M | 7.82 M | -23.6 M | -37.7 M | -37.8 M | -32.9 M | -33.8 M | -29.2 M | -25.1 M | -15.2 M | -38.7 M | -30.9 M | -36.2 M | -26.6 M | -26.4 M | -31.1 M | -39.4 M | -21 M | -19 M | -17.7 M | -12.6 M | -7.4 M | -47.6 M | -5.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
61 K | 513 K | 1.14 M | - | 5.34 M | 2.89 M | 9.85 M | - | 42 K | 6.36 M | 6.77 M | - | 6.2 M | 379 K | 6.5 M | 11.4 M | 62.8 M | 10.7 M | 5.72 M | 12.3 M | 3.85 M | 2.33 M | 2.07 M | 6.12 M | 14.5 M | 7.37 M | 3.93 M | 3.67 M | 6.28 M | 3.1 M | 682 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-65.7 M | -71.9 M | -67 M | - | -50.2 M | -44.1 M | -51 M | - | -57.5 M | -54.2 M | -50.8 M | - | -39.3 M | -55.4 M | -56.9 M | - | 8.99 M | -31.3 M | -46.6 M | - | -34.6 M | -35.6 M | -31.3 M | -26.3 M | -16.3 M | -39.7 M | -31.6 M | - | -26.7 M | -26.1 M | -30.6 M | - | -21.2 M | -19.2 M | -17.8 M | - | -7.38 M | -10.4 M | -5.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-5 K | -1 K | 6 K | - | - | -7 K | -1.58 M | - | 1 K | 235 K | -234 K | - | 19 K | -1 K | 21 K | - | -1.4 M | 7.18 M | 7.33 M | - | -33 K | -68 K | -44 K | - | -4 K | 154 K | 182 K | - | 196 K | 122 K | 140 K | - | 3 K | 5 K | -30 K | - | 21 K | -37.1 M | -99 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -65.6 M | - | - | - | -49.4 M | - | -52.8 M | -54.2 M | -49.2 M | - | -35.7 M | -55.4 M | -55.7 M | - | 11.8 M | -29.7 M | -45.8 M | - | -32.5 M | -34.3 M | -30.6 M | -26.3 M | -13.9 M | -38.1 M | -30.8 M | - | -24.8 M | -24.8 M | -30 M | - | -20.5 M | -18.8 M | -17.7 M | - | -7.06 M | -10.2 M | -5.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
65.7 M | 72.4 M | 68.1 M | - | 55.5 M | 47 M | 60.8 M | - | 57.6 M | 60.6 M | 57.5 M | - | 45.4 M | 55.8 M | 63.4 M | 77.3 M | 53.9 M | 42.1 M | 52.3 M | 51.7 M | 38.4 M | 38 M | 33.3 M | 32.4 M | 30.8 M | 47 M | 35.5 M | 40.1 M | 33 M | 29.2 M | 31.3 M | 39.9 M | 22.1 M | 22.6 M | 18.6 M | 13.2 M | 8.05 M | 10.6 M | 5.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
18.1 M | 18.2 M | 19.3 M | - | 15 M | 17.2 M | 23 M | - | 16.2 M | 16.9 M | 19.5 M | - | 16.2 M | 22 M | 21.4 M | - | 19.9 M | 14.1 M | 17.8 M | - | 15.7 M | 14.4 M | 17.5 M | - | 13.3 M | 14.3 M | 14.2 M | - | 12.6 M | 11.9 M | 12.3 M | - | 11.3 M | 12.2 M | 9.76 M | - | 4.2 M | 3.28 M | 3.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency